Applied DNA Sciences's EBIT per Share for the
three
months ended in Dec. 2023 was $-5.54.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-20.31.
During the past 3 years, the average EBIT per Share Growth Rate was 36.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 44.80% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 31.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Applied DNA Sciences's EBIT per Share or its related term are showing as below:
APDN'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 1 Med: 27.85 Max: 72.8
Current: 36
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Applied DNA Sciences was 72.80% per year. The lowest was 1.00% per year. And the median was 27.85% per year.
APDN's 3-Year EBIT Growth Rate is ranked better than 84.83% of 178
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.55
vs APDN: 36.00
Applied DNA Sciences EBIT per Share Historical Data
The historical data trend for Applied DNA Sciences's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-20.31
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Applied DNA Sciences (NAS:APDN) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Applied DNA Sciences EBIT per Share Related Terms
Thank you for viewing the detailed overview of Applied DNA Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Applied DNA Sciences (Applied DNA Sciences) Business Description
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
APDN has been successfully added to your 